Preliminary Results on Heparin-Modified Double-Layered PCL and PLA-Based Scaffolds for Tissue Engineering of Small Blood Vessels
Source abstract
Abstract
Low-diameter blood vessels are challenging to replace with more traditional synthetic vascular grafts. Therefore, the obvious choice is to try to regenerate small veins and arteries through tissue-engineering approaches. However, the layered structure of native vessels and blood compatibility issues make this a very challenging task. The aim of this study is to create double-layered tubular scaffolds with enhanced anticoagulant properties for the tissue engineering of small blood vessels. The scaffolds were made of a polycaprolactone-based porous outer layer and a polylactide-based electrospun inner layer modified with heparin. The combination of thermally induced phase separation and electrospinning resulted in asymmetric scaffolds with improved mechanical properties. The release assay confirmed that heparin is released from the scaffolds. Additionally, anticoagulant activity was shown through APTT (activated partial thromboplastin time) assay. Interestingly, the endothelial cell culture test revealed that after 14 days of culture, HAECs (human aortic endothelial cell lines) tended to organize in chain-like structures, typical for early stages of vascular formation. In the longer culture, HAEC viability was higher for the heparin-modified scaffolds. The proposed scaffold design and composition have great potential for application in tissue engineering of small blood vessels.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Kraków, Poland
Funding
The subsidy of the Ministry of Education and Science for the AGH University of Science and Technology in Kraków
References (27)
Show source-provided references
1. Vascular heterogeneity and specialization in development and disease10.1038/nrm.2017.36 ↗
2. European Society of Cardiology: Cardiovascular Disease Statistics 201910.1093/eurheartj/ehz859 ↗
3. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery10.33549/physiolres.931918 ↗
4. Wise, D.L., Trantolo, D.J., Lewandrowski, K.-U., Gresser, J.D., and Cattaneo, M.V. (2000). Endothelialization of Vascular Prostheses. Biomaterials Engineering and Devices: Human Applications Volume 1: Fundamentals and Vascular and Carrier Applications, The Humana Press Inc.10.1385/1592591973 ↗
5. Progresses in Synthetic Vascular Prostheses: Toward the Endothelialization10.1007/978-1-4615-0063-6_13 ↗
6. Polydopamine and gelatin coating for rapid endothelialization of vascular scaffolds
7. Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise10.1016/j.stem.2018.02.009 ↗
8. A blood vessel model constructed from collagen and cultured vascular cells10.1126/science.2934816 ↗
9. Tissue-engineered Vascular Grafts: Balance of the Four Major Requirements10.1016/j.colcom.2018.01.005 ↗
10. Viscoelastic properties of multi-layered cellularized vascular tissues fabricated from collagen gel10.1016/j.jmbbm.2018.01.021 ↗
11. Small-diameter vascular tissue engineering10.1038/nrcardio.2013.77 ↗
12. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling10.1073/pnas.0911465107 ↗
13. A Novel Single-Step Self-Assembly Approach for the Fabrication of Tissue-Engineered Vascular Constructs10.1089/ten.tea.2009.0313 ↗
14. Fiqrianti, I.A., Widiyanti, P., Manaf, M.A., Savira, C.Y., Cahyani, N.R., and Bella, F.R. (2018). Poly-L-lactic Acid (PLLA)-Chitosan-Collagen Electrospun Tube for Vascular Graft Application. J. Funct. Biomater., 9.10.3390/jfb9020032 ↗
15. Progress in heparin and heparin-like/mimicking polymer-functionalized biomedical membranes10.1039/C4TB01390E ↗
16. Matsuzaki, Y., Ulziibayar, A., Shoji, T., and Shinoka, T. (2021). Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts. Appl. Sci., 11.10.3390/app11104563 ↗
17. Nanofibrous Heparin and Heparin-Mimicking Multilayers as Highly Effective Endothelialization and Antithrombogenic Coatings10.1021/bm501882b ↗
18. The applications of heparin in vascular tissue engineering10.1016/j.mvr.2020.104027 ↗
19. NIH Image to ImageJ: 25 Years of image analysis10.1038/nmeth.2089 ↗
20. Chemical and physical modifications of electrospun fibers as a method to stimulate tissue regeneration—minireview
21. Bioactive nano yarns as surgical sutures for wound healing10.1016/j.msec.2021.112334 ↗
22. PLA-Based Hybrid and Composite Electrospun Fibrous Scaffolds as Potential Materials for Tissue Engineering10.1155/2017/9246802 ↗
23. The mechanical characterization of blood vessels and their substitutes in the continuous quest for physiological-relevant performances. A critical review10.1016/j.mtbio.2021.100106 ↗
24. Mechanical Properties of Electrospun Fibers—A Critical Review10.1002/adem.202100153 ↗
25. Approaches to Fabricating Multiple-Layered Vascular Scaffolds Using Hybrid Electrospinning and Thermally Induced Phase Separation Methods10.1021/acs.iecr.5b03462 ↗
26. Heparin-Eluting Electrospun Nanofiber Yarns for Antithrombotic Vascular Sutures10.1021/acsami.7b14888 ↗
27. Polylactide- and polycaprolactone-based substrates enhance angiogenic potential of human umbilical cord-derived mesenchymal stem cells in vitro - implications for cardiovascular repair10.1016/j.msec.2017.03.281 ↗